article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. president of the Cardiac Surgery business in the Medtronic Cardiovascular portfolio.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. president of the Cardiac Surgery business in the Medtronic Cardiovascular portfolio.

article thumbnail

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

In his year-long term as President of HVS, Dr. El-Hamamsy will focus on fostering collaboration among cardiologists, surgeons, and researchers, as well as promoting awareness and encouraging innovation to reduce the burden of heart valve disease globally.

article thumbnail

Gene therapy offers hope for rare, deadly heart disease in young men

Medical Xpress - Cardiology

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy that could transform the treatment of arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and highly penetrant inherited cardiac disorder with an elevated risk of sudden cardiac death.

article thumbnail

Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis

Frontiers in Cardiovascular Medicine

The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heart failure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing.

article thumbnail

EV ICD Global Pivotal Trial Results Demonstrate High ATP Success, Effective Defibrillation

DAIC

The EV ICD Pivotal Trial is a prospective, multicenter, single-arm, non-randomized, pre-market clinical study that assessed the safety and effectiveness of the Medtronic EV-ICD system for patients at risk of sudden cardiac death. Primary results were published in The New England Journal of Medicine.

article thumbnail

Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award

DAIC

The work has extended beyond conventional approaches by also utilizing warning symptoms of impending sudden cardiac death combined with other biological markers. “Dr. Chugh is widely regarded among our electrophysiology community as one of our most innovative, dedicated and talented researchers.